Senior Marketing Data Scientist

Microdosing Ozempic: startup Noom launches prevention-focused program. American digital health platform offers medication in low doses for US$149 monthly for users with BMI from 21; strategy targets longevity market estimated at US$8 trillion by 2030. Noom, the American digital health platform known for its dietary habit change app, has launched a program that combines GLP-1 class medications, which include Ozempic and Mounjaro, in microdoses with biomarker monitoring and behavioral coaching. The service, named Proactive Health Microdose GLP-1 Rx, costs US$149 per month (about R$900) and is available to people with a body mass index (BMI) from 21 - a lower threshold than traditionally required for prescription of these drugs. GLP-1 agonists, the class of medications that includes semaglutide (active ingredient in Ozempic and Wegovy) and tirzepatide (Mounjaro), are approved for type 2 diabetes and obesity treatment. Prescription typically requires BMI equal to or above 30, or above 27 in cases of associated comorbidities. Noom's proposal differs from traditional GLP-1 offerings by positioning the medication as a preventive health tool, rather than just for weight loss. The program includes sending personalized doses to users and at-home blood tests every four months, which monitor 17 biomarkers related to metabolic, cardiovascular, and hormonal health. Results are integrated into the company's app, which already offers habit-building tools. The launch occurs at a time of accelerated expansion of GLP-1 use in the United States. Gallup research indicates that 12.4% of American adults report using medications like Ozempic and Wegovy for weight loss - more than double the rate recorded at the beginning of 2024. The growth is mainly driven by middle-aged adults. Data from Ro, a telehealth company, shows that familiarity with the medications directly influences public perception: people who know someone using GLP-1 tend to have a more favorable view of the class. In Brazil, GLP-1 medications like Ozempic and Wegovy are regulated by Anvisa (National Health Surveillance Agency) and require medical prescription. There has been no announcement, so far, about expanding Noom's program to the Brazilian market.

Castlight Health partners with Noom to expand access to personalized programs for weight and chronic conditions. News provided by. Castlight's personalized health benefits platform provides seamless access to Noom's health programs including diabetes, GLP-1s and weight support for employers and health plans. SEATTLE and NEW YORK, Dec. 8, 2025 /PRNewswire/ - Castlight Health, the leading health navigation platform, and Noom, the leading platform for preventive health, today announced a new partnership to bring Noom's program to Castlight's extensive ecosystem of health and wellbeing partners. Through this collaboration, employers can purchase Noom directly through Castlight, allowing members to seamlessly discover, access, and enroll in Noom programs - including Noom Weight, Noom Med, Noom Diabetes, and Noom Diabetes Prevention - directly through the Castlight app. Members also gain access to GLP-1s through Noom Med, helping those prescribed these medications integrate them effectively with lifestyle and behavior change for sustainable health outcomes. Supported by Castlight's personalized navigation and Care Guide services, members will receive timely nudges and recommendations that connect them with Noom's psychology-based program to build healthier habits, achieve weight management and health goals, and improve long-term wellbeing. "Weight management is one of the most urgent and costly challenges employers and health plans face today," said Victor Leclere, SVP of Commercial at Castlight Health. "By embedding Noom into our ecosystem of 40+ partners - and powering it with Castlight's proven ability to drive a 3.25x increase in engagement - we're giving employers and health plans a smarter, more sustainable alternative to rising drug costs and a better way to support their members." Noom's program leverages cognitive behavioral techniques, coaching, and technology to help users create sustainable lifestyle changes. By embedding into Castlight's connected navigation platform, Noom will reach more individuals at critical moments in their health journey, removing barriers to discovery and making it easier for people to take action. The deep integration between Castlight and Noom helps incentivize members to complete micro-behaviors, linked to sustained engagement with the Noom program. Allowing employers to reward members for completing different activities, together, help members achieve long-term lifestyle changes aligned to their weight management goals. "At Noom, we believe small, science-backed changes can lead to lasting health improvements," said Cody Fair, Noom's Chief Commercial Officer. "Partnering with Castlight allows us to expand our reach and ensure that more employees and health plan members can benefit from our program, supported by Castlight's proven navigation and engagement capabilities." Castlight Health and Noom invite you to join their upcoming webinar "Coffee Break with Castlight: Mindful Eating with Noom" where you'll hear directly from a Noom clinical leader on mindful eating during the busy new year. Register here: castlight.co/noom About Castlight Health Castlight Health simplifies healthcare navigation by providing a comprehensive and highly tailored digital platform and clinical services. Leveraging advanced personalization capabilities, Castlight identifies individual needs to deliver customized health and wellbeing experiences, guiding individuals through their unique health journeys and helping them engage with the right programs and care at the right time. Founded in 2008, Castlight enables large employers and health plans to drive better outcomes, improve engagement and maximize the value of healthcare benefits. apree health, the parent company of Castlight Health, is a business unit of Mosaic Health. For more information, visit www.castlighthealth.com. About Noom Noom is the leading platform for preventive health and longevity solutions, empowering everyone, everywhere to live better longer - every day. Noom Health partners with top health plans and employers to offer a suite of solutions, including Noom Med, Noom Med with SmartRx, Noom Weight, Noom Weight with GLP-1Rx, Noom Diabetes, and Noom Diabetes Prevention Program, to millions. Noom has received multiple National Institute of Health grants and was the first mobile app recognized by the CDC as a certified diabetes prevention program. With offices in New York City and Princeton, NJ, Noom has been named one of Inc.'s Best Places to Work and Fortune's Best Workplaces in Technology. About Mosaic Health Mosaic Health is a national care delivery platform focused on expanding access to comprehensive primary care for consumers with coverage across Commercial, Individual Exchange, Medicare, and Medicaid health plans. The Business Units which comprise Mosaic Health, including apree health, Millennium Physician Group, and CareMore Health, are multi-payer and serve nearly one million consumers across 19 states, providing them with access to high quality primary care, integrated care teams, personalized navigation, expanded digital access, and specialized services for higher-need populations. Through Mosaic Health, health plans and employers have an even stronger care provider partner that delivers affordability and superior experiences for their members and employees, including value-based primary care capacity integrated with digital patient engagement and navigation. Each of the companies within Mosaic Health provide unique offerings that together promise to improve individuals' health and wellbeing, while helping care providers deliver higher quality care. For more information, please visit www.mosaichealth.com or follow Mosaic Health on LinkedIn. SOURCE Castlight Health

Highmark partnering with Noom to tackle obesity. Highmark has announced that it is partnering with Noom, a preventative health provider, to help its customers get healthier and lose weight. Maria Baker, Highmark vice president of health strategy and delivery, said that with nearly 74% of U.S. adults overweight and obese costing the health system $173 billion annually, Highmark and Noom are combining resources to address the issue. Currently, about 2 million of Highmark's customers will be eligible to participate in the Noom program for free. To be eligible, an individual needs to have a BMI of over 25. Those under that level can still participate in the program at a discount off the regular consumer cost. The program has three levels or "journeys," Baker said. The first is core weight management, the second is diabetes prevention, and the third is managing a diabetes lifestyle. An assessment questionnaire that new users take will assess which journey they need to be on and AI support will track progress to show if that person needs to move up or down a program as they progress. All journeys offer bite-sized lessons, artificial intelligence (AI)-powered smart tools, one-on-one support and peer communities. "This is definitely something we've been pursuing for years," Baker said. "Focusing on sick patients has driven up costs. People get sicker and sicker, so now we focus on some of the underlying cause like sleep, nutrition and exercise." Noom offers a whole-person health approach to weight management. By leveraging behavior change and habit formation techniques, personalized coaching and cutting-edge technology. "Highmark and Noom are both dedicated to building a world-class customer experience for the people we serve by engaging them when, where and how is best for them," said Tracy Saula, chief product and experience officer at Highmark Health. "Our members will find that Noom: Weight Management is customized to their unique needs and goals, guiding them toward implementing changes and ultimately sustaining a healthy routine." For members who struggle to maintain progress or experience gradual weight gain, Noom's psychology-based lessons help members understand the "why" behind their habits, improve their relationship with food and reframe setbacks as part of the journey. AI-powered tools - including smart food logging, body scan technology and automated progress tracking - provide real-time insights that make healthy choices easier. Integration with wearables seamlessly captures activity, giving members a holistic view of their progress. Baker said there are similar programs on the market, but Highmark chose to go with Noom because their missions are closely aligned. "We really like the way Noom addresses consumer behavior and focuses on lifestyle. They would probably describe themselves as a behavior company with weight management being what they started with. Additionally, Noom's GLP-1 Companion is available to members across all journeys who self-report they are taking a GLP-1 medication. This feature offers customized content such as protein intake guidance, strategies to help retain muscle and information on managing side effects. "Health is more than managing weight or a diagnosis - it's about creating lasting habits that support overall well-being," said Cody Fair, chief commercial officer at Noom. "Through our collaboration with Highmark, members will gain access to AI-powered tools like body scan technology and smart food logging, providing real-time insights, making healthier choices easier and helping drive sustainable long-term outcomes." Fair noted that obesity can increase a person's risk for hypertension, type 2 diabetes and coronary heart disease - with huge associated costs to the health care system. Studies have shown that weight loss of 5 to 10 percent can lead to clinically meaningful results and reduce the economic impact of costly comorbidities. Highmark will begin offering the Noom program to members starting Jan. 1. Members can confirm their eligibility by logging on to their My Highmark mobile app or web portal at myhighmark.com.